Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $360.09 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Blue Earth Diagnostics Limited | $124.02 | 2 | $0 (2022) |
| Progenics Pharmaceuticals, Inc. | $103.86 | 1 | $0 (2022) |
| Abbott Laboratories | $82.77 | 1 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $34.78 | 1 | $0 (2023) |
| Daiichi Sankyo Inc. | $14.66 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $117.55 | 2 | Abbott Laboratories ($82.77) |
| 2022 | $227.88 | 3 | Blue Earth Diagnostics Limited ($124.02) |
| 2020 | $14.66 | 1 | Daiichi Sankyo Inc. ($14.66) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/09/2023 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: Oncology | ||||||
| 05/11/2023 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $82.77 | General |
| Category: Vascular | ||||||
| 09/16/2022 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Diagnostic Imaging | ||||||
| 05/24/2022 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $97.93 | General |
| Category: Diagnostic Imaging | ||||||
| 04/07/2022 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $103.86 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/09/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 2,827 | 17,624 | $1.8M | $358,436 |
| 2022 | 43 | 2,946 | 13,145 | $1.5M | $313,955 |
| 2021 | 46 | 2,983 | 17,623 | $1.1M | $194,724 |
| 2020 | 38 | 2,156 | 8,561 | $658,924 | $100,770 |
All Medicare Procedures & Services
216 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | Office | 2023 | 24 | 221 | $360,712 | $103,984 | 28.8% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 65 | 66 | $315,725 | $76,316 | 24.2% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2023 | 259 | 281 | $97,463 | $24,198 | 24.8% |
| 74183 | Mri scan of abdomen before and after contrast | Office | 2023 | 70 | 72 | $215,006 | $18,724 | 8.7% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 127 | 127 | $69,850 | $17,023 | 24.4% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Facility | 2023 | 207 | 207 | $38,176 | $10,403 | 27.3% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 43 | 44 | $14,124 | $8,624 | 61.1% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 127 | 128 | $62,194 | $8,538 | 13.7% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 60 | 60 | $43,290 | $8,381 | 19.4% |
| 74183 | Mri scan of abdomen before and after contrast | Facility | 2023 | 95 | 99 | $55,193 | $8,032 | 14.6% |
| 72197 | Mri scan of pelvis before and after contrast | Facility | 2023 | 69 | 71 | $39,259 | $5,751 | 14.6% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 149 | 152 | $47,180 | $5,745 | 12.2% |
| 72197 | Mri scan of pelvis before and after contrast | Office | 2023 | 30 | 32 | $66,228 | $5,703 | 8.6% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 52 | 53 | $41,600 | $4,657 | 11.2% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 73 | 73 | $32,984 | $4,532 | 13.7% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 64 | 64 | $29,362 | $4,068 | 13.9% |
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 125 | 125 | $27,225 | $3,771 | 13.9% |
| 77067 | Screening mammography | Facility | 2023 | 98 | 98 | $20,188 | $3,478 | 17.2% |
| 74170 | Ct scan of abdomen before and after contrast | Office | 2023 | 25 | 25 | $23,079 | $3,400 | 14.7% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 77 | 77 | $25,345 | $3,207 | 12.7% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Facility | 2023 | 40 | 40 | $21,405 | $2,894 | 13.5% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 12 | 12 | $13,200 | $2,793 | 21.2% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 99 | 99 | $16,038 | $2,791 | 17.4% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 82 | 8,300 | $4,897 | $2,173 | 44.4% |
| 74181 | Mri scan of abdomen without contrast | Facility | 2023 | 39 | 39 | $13,670 | $2,080 | 15.2% |
About Dr. Jerry Watson, M.D
Dr. Jerry Watson, M.D is a Diagnostic Radiology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497771216.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerry Watson, M.D has received a total of $360.09 in payments from pharmaceutical and medical device companies, with $117.55 received in 2023. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($360.09).
As a Medicare-enrolled provider, Watson has provided services to 10,912 Medicare beneficiaries, totaling 56,953 services with total Medicare billing of $967,886. Data is available for 4 years (2020–2023), covering 216 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Diagnostic Radiology
- Location Raleigh, NC
- Active Since 07/14/2006
- Last Updated 04/27/2023
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1497771216
Products in Payments
- Axumin (Drug) $124.02
- PYLARIFY (Drug) $103.86
- XIENCE SKYPOINT (Device) $82.77
- Xofigo (Drug) $34.78
- INJECTAFER (Drug) $14.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Raleigh
Julia Taber, M.d, M.D
Diagnostic Radiology — Payments: $162,769
Satish Mathan, M.d, M.D
Diagnostic Radiology — Payments: $24,756
Dr. David Sopko, M.d, M.D
Diagnostic Radiology — Payments: $21,735
Dr. John Bardini, Md, MD
Diagnostic Radiology — Payments: $21,384
Dr. Danielle Wellman, Md, MD
Diagnostic Radiology — Payments: $21,118
Eithne Burke, M.d, M.D
Diagnostic Radiology — Payments: $20,826